Skip to content
info@acplgroupindia.co.in +91-9266665201 Mon – Sat: 10:00 AM – 6:00 PM
Accredited Consultant
  • Home
  • About
  • Services
    • Regulatory Services

      • CDSCO Registration
      • FSSAI Licensing
      • BIS Certification
      • DGFT Approvals
      • WPC Approval
      • EPR Registration
      • Legal Metrology
    • Specialized Services

      • Pharmacovigilance
      • Cosmetovigilance
      • Materiovigilance
      • Food Safety Vigilance
      • Clinical Trials
      • Field Safety Trials
    • More Services

      • DSIR Recognition
      • ICMR Approvals
      • NPPA Compliance
      • Narcotics (CBN)
      • PCPNDT Compliance
      • India Entry Strategy
  • India Entry
  • Newsletter
    • Volume 22
    • Volume 23
    • Volume 24
    • Volume 25
    • Volume 26
    • Volume 27
    • Volume 28
    • Volume 29
    • Volume 30
    • Volume 31
    • Volume 32
  • Blog
  • Contact
Get Started
Accredited Consultant
  • Home
  • About
  • Services
    • Regulatory Services
      • CDSCO Registration
      • FSSAI Licensing
      • BIS Certification
      • DGFT Approvals
      • WPC Approval
      • EPR Registration
      • Legal Metrology
    • Specialized Services
      • Pharmacovigilance
      • Cosmetovigilance
      • Materiovigilance
      • Food Safety Vigilance
      • Clinical Trials
      • Field Safety Trials
    • More Services
      • DSIR Recognition
      • ICMR Approvals
      • NPPA Compliance
      • Narcotics (CBN)
      • PCPNDT Compliance
      • India Entry Strategy
  • India Entry
  • Newsletter
    • Volume 22
    • Volume 23
    • Volume 24
    • Volume 25
    • Volume 26
    • Volume 27
    • Volume 28
    • Volume 29
    • Volume 30
    • Volume 31
    • Volume 32
  • Blog
  • Contact
Call Us: +91-9266665201 info@acplgroupindia.co.in
  1. Home
  2. ACPL

ACPL

ACPL
Oct 27, 2026

FSSAI Proposes Ban on Added Sucrose and Fructose in Infant Foods for Babies Up to Six Months

FSSAI Proposes Ban on Added Sucrose and Fructose in Infant Foods | ACPL Food Regulatory Update · India FSSAI Proposes…

Read More
ACPL
Oct 27, 2026

FSSAI Proposes Ban on Added Sucrose and Fructose in Infant Foods for Babies Up to Six Months

Read More
ACPL
Oct 27, 2026

FSSAI Proposes New Pesticide Residue Limits for Tea: Draft Amendment 2026

FSSAI Draft MRLs for Acetamiprid & Imidacloprid in Tea | 2026 Regulatory Update · FSSAI · Food Safety FSSAI Proposes…

Read More
ACPL
Oct 27, 2026

Uttar Pradesh Makes BIS Certification Mandatory for Packaged Drinking Water and Mineral Water: 2026 Regulatory Update

BIS Certification for Packaged Drinking Water in Uttar Pradesh | 2026 Regulatory Update · Food Safety · Uttar Pradesh BIS…

Read More
ACPL
Oct 27, 2026

Uttar Pradesh Makes BIS Certification Mandatory for Packaged Drinking Water and Mineral Water: 2026 Regulatory Update

Uttar Pradesh FSDA makes BIS certification mandatory for packaged drinking water and mineral water units. Check the 2027 deadline and…

Read More
ACPL
Oct 27, 2026

DGHS Directs Ban on Reuse of Single-Use Medical Devices in India

DGHS directs strict enforcement against reuse of single-use medical devices in India. Learn about patient safety, compliance risks and hospital…

Read More
ACPL
Oct 14, 2026

CDSCO Issues Draft Guidance for Manufacturing In-Vitro Diagnostic Medical Devices in India

CDSCO Draft IVD Manufacturing Guidance 2026 | ACPL ACPLACCREDITED CONSULTANTS PVT. LTD.Visit ACPL Website Medical Device Regulatory Update · 9…

Read More
ACPL
Oct 14, 2026

CDSCO Clarifies Export NOC Requirements for Already Approved r-DNA Drug Products

CDSCO Export NOC for r-DNA Drugs: 2026 Update | ACPL ACPL ACCREDITED CONSULTANTS PVT. LTD. Visit ACPL Website Pharmaceutical Regulatory…

Read More
ACPL
Sep 16, 2026

Make in India and Public Procurement of Medical Devices: What Manufacturers Should Know

Medical Devices CDSCO Consultant in India

Read More
ACPL
Aug 31, 2026

Medical Devices (Third Amendment) Rules, 2026: EU Countries Added to Rule 63 | CDSCO Update

CDSCO Medical Device Regulatory Update Medical Devices (Third Amendment) Rules, 2026: EU Countries Added to Rule 63 Understanding the key…

Read More
1 2 3 … 5 Next →
Accredited Consultant

India's trusted pharma regulatory affairs consultancy. Over 25 years helping businesses navigate CDSCO, FSSAI, BIS, and all major Indian regulatory frameworks.

Quick Links

  • About ACPL
  • Our Services
  • India Entry Strategy
  • Insights & Blog
  • Contact Us
  • Careers

Key Services

  • CDSCO Registration
  • FSSAI Licensing
  • BIS Certification
  • Pharmacovigilance
  • Clinical Trials
  • EPR Registration

Contact Us

  • B-3, Sector-6, Noida – 201301, Uttar Pradesh, India
  • +91-9266665201
    +91-9310040434
  • info@acplgroupindia.co.in
  • Mon – Sat: 10:00 AM – 6:00 PM

© 2026 Accredited Consultants Private Limited. All rights reserved.

  • Privacy Policy
  • Terms & Conditions
Scroll to Top